Page last updated: 2024-11-07

dextroamphetamine and Cognitive Dysfunction

dextroamphetamine has been researched along with Cognitive Dysfunction in 2 studies

Dextroamphetamine: The d-form of AMPHETAMINE. It is a central nervous system stimulant and a sympathomimetic. It has also been used in the treatment of narcolepsy and of attention deficit disorders and hyperactivity in children. Dextroamphetamine has multiple mechanisms of action including blocking uptake of adrenergics and dopamine, stimulating release of monamines, and inhibiting monoamine oxidase. It is also a drug of abuse and a psychotomimetic.
(S)-amphetamine : A 1-phenylpropan-2-amine that has S configuration.

Cognitive Dysfunction: Diminished or impaired mental and/or intellectual function.

Research Excerpts

ExcerptRelevanceReference
"Schizophrenia is a chronic severe mental disorder with a presumed neurodevelopmental origin, and no effective treatment."1.43Genetic blockade of adenosine A2A receptors induces cognitive impairments and anatomical changes related to psychotic symptoms in mice. ( Ciruela, F; Gracia-Rubio, I; Moscoso-Castro, M; Valverde, O, 2016)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Chaves Filho, AJM1
Cunha, NL1
Rodrigues, PA1
de Souza, AG1
Soares, MV1
Jucá, PM1
de Queiroz, T1
Clemente, DCDS1
Mottin, M1
Andrade, CH1
Peixoto, CA1
Macedo, DS1
Moscoso-Castro, M1
Gracia-Rubio, I1
Ciruela, F1
Valverde, O1

Other Studies

2 other studies available for dextroamphetamine and Cognitive Dysfunction

ArticleYear
Doxycycline reverses cognitive impairment, neuroinflammation and oxidative imbalance induced by D-amphetamine mania model in mice: A promising drug repurposing for bipolar disorder treatment?
    European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology, 2021, Volume: 42

    Topics: Animals; Antimanic Agents; Bipolar Disorder; Cognitive Dysfunction; Dextroamphetamine; Disease Model

2021
Genetic blockade of adenosine A2A receptors induces cognitive impairments and anatomical changes related to psychotic symptoms in mice.
    European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology, 2016, Volume: 26, Issue:7

    Topics: Animals; Brain; Brain-Derived Neurotrophic Factor; Cognitive Dysfunction; Dextroamphetamine; Disease

2016